Vimarsana
Biggest News Aggregation in the World

Lam Kong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lam Kong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lam Kong Today - Breaking & Trending Today

Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia - Vimarsana News

Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia

Published: March 31, 2023

HONG KONG, Mar 31, 2023 - (ACN Newswire) - On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint venture to develop and commercialize toripalimab in Thailand, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Vietnam[1].From left to right: CEO of Junshi Biosciences,...

Source: asiaone.com
Related Topics:
United StatesChong TanRepublic OfUnited KingdomJunshi BiosciencesXiong JunChina Medical System Holdings LimitedRxilient BiotechLegend CapitalManaging DirectorExecutive DirectorChief ExecutiveLam KongLee KerSoutheast AsiaSoutheast Asian
Legend Capital: Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia - Vimarsana News

Legend Capital: Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia

Published: March 31, 2023

HONG KONG, Mar 31, 2023 - (ACN Newswire) - On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint

Source: finanznachrichten.de
Related Topics:
Republic OfUnited StatesUnited KingdomChong TanJunshi BiosciencesXiong JunChina Medical System Holdings LimitedRxilient BiotechLegend CapitalManaging DirectorExecutive DirectorChief ExecutiveLam KongLee KerSoutheast AsiaSoutheast Asian
Incyte and CMS Announce Collaboration and License Agreement for Ruxolitinib Cream in Greater China and Southeast Asia - Vimarsana News

Incyte and CMS Announce Collaboration and License Agreement for Ruxolitinib Cream in Greater China and Southeast Asia

Published: December 2, 2022

02.12.2022 - Incyte (NASDAQ:INCY) and CMS Aesthetics, a dermatology medical aesthetic company and subsidiary of CMS (HKEX: 00867), today announced that the companies have entered into a Collaboration and License Agreement for the development and ... Seite 1

Source: wallstreet-online.de
Related Topics:
United StatesHong KongChief Executive OfficerGreater ChinaSoutheast AsiaLam KongChief Executive